Friess Associates LLC Avantor, Inc. Transaction History

Friess Associates LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$29.35 - $34.19 $349,587 - $407,237	-11,911 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$32.56 - $40.56 $12,893 - $16,061	396 Added 3.44%	11,911 $403,000
Q4 2021 Feb 11, 2022	BUY	$36.93 - $42.14 $89,407 - $102,020	2,421 Added 26.62%	11,515 $485,000
Q3 2021 Nov 12, 2021	BUY	$35.36 - $44.01 $191,969 - $238,930	5,429 Added 148.13%	9,094 $372,000
Q2 2021 Aug 11, 2021	BUY	$29.45 - $35.85 $3,416 - $4,158	116 Added 3.27%	3,665 $130,000
Q1 2021 May 14, 2021	SELL	$26.83 - $30.69 $22.1 Million - $25.3 Million	-823,951 Reduced 99.57%	3,549 $103,000
Q4 2020 Feb 12, 2021	BUY	$22.9 - $28.15 $18.9 Million - $23.3 Million	827,500 New	827,500 $23.3 Million

572

647M

2.47M

8.7M

Ticker AVTR
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 674,035,008
Market Cap $14.2B
Description
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulate...

Get notified when there are updates to the investment portfolio of Friess Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Friess Associates LLC with notifications on news.